Stay updated on Telisotuzumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Difference
    20%
    Check dated 2026-09-22T23:27:28.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now lists additional study sites and a Find contact information entry, signaling an expanded network of locations and updated access to study contacts for the trial.
    Difference
    0.1%
    Check dated 2026-09-15T22:21:36.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.6, replacing the previous v3.6.5, indicating an administrative update to the record. This does not reflect changes to the study details themselves.
    Difference
    0.0%
    Check dated 2026-09-01T18:20:52.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A line reading '2023 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH funding for the trial. This adds funding attribution to the study record.
    Difference
    0.0%
    Check dated 2026-08-25T20:52:22.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.4 to v3.6.5, indicating a minor update to the page revision history.
    Difference
    0.0%
    Check dated 2026-08-11T22:06:11.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Three site entries were edited to standardize their names by removing diacritics and minor punctuation: Intermountain Health St Vincent Regional Hospital - Cancer Centers of Montana /ID# 253147; Hospital Da Crianca Santo Antonio /ID# 233249; and Fundacion Ctic - Centro De Tratamiento E Investigacion Sobre Cancer Luis Carlos /ID# 258131.
    Difference
    0.1%
    Check dated 2026-07-28T19:22:38.000Z thumbnail image

Stay in the know with updates to Telisotuzumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page.